Mesothelioma Research Archives: August 2012
Antifungal Rx may one day double as chemo for mesothelioma, other cancers, http://www.utexas.edu/news/2012/08/21/antifungal-drug-decreases-tumor-growth-promising-as-cancer-therapy/ , 8/29/12
Mesothelioma stem cells may be real, might constitute a target for therapies, http://www.nature.com/news/cancer-stem-cells-tracked-1.11087 , 8/21/12
Plant compound probably isn't a mesothelioma-fighting miracle drug, http://www.spandidos-publications.com/10.3892/ijmm.2012.1075 , 8/17/12
British hospital starts mesothelioma tissue bank, http://www.papworthhospital.nhs.uk/latestnews/index.php?newsid=212 , 8/17/12
Chrysotile asbestos causes mesothelioma worldwide, despite what biased 'experts' say, http://www.annalsofepidemiology.org/article/S1047-2797(11)00180-3/abstract , 8/16/12
Experimental drug for mesothelioma will enter Phase II clinical trial, http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-newsArticle&ID=1724962&highlight= , 8/14/12
UPenn scientists work on immune therapy for mesothelioma, http://blogs.nature.com/news/2012/08/novartis-gives-upenn-20-million-for-cancer-vaccine.html , 8/10/12
Melanoma antigen probably isn't a marker for mesothelioma, http://journals.lww.com/appliedimmunohist/Abstract/publishahead/Melan_A__A103__is_not_a_Marker_of_Mesothelioma.99545.aspx, 8/8/12
Genetic mutation related to thyroid hormones may play part in mesothelioma, http://www.ncbi.nlm.nih.gov/pubmed/22842620 , 8/3/12